Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Maeda

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2015
[Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma]Ayako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
Modern Rheumatology|February 14, 2016
Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sjögren's syndromeAkihiro Mukaino, Shunya Nakane, Osamu Higuchi, et al.
Clinical and Experimental Rheumatology|November 7, 2023
Exploratory study on quantitative assessment of skin hardness in patients with systemic sclerosis using SOFTGRAMHiraku Kokubu, Yasuaki Ikuno, Kazuyuki Uchiyama, et al.
International Journal of Hematology|May 19, 2009
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALLArinobu Tojo, Kensuke Usuki, Akio Urabe, et al.
International Journal of Clinical Oncology|November 14, 2018
Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial)Shin Fujisawa, Yasunori Ueda, Kensuke Usuki, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 4, 2018
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line TreatmentMasaya Okada, Jun Imagawa, Hideo Tanaka, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2015
[Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma]Ayako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
Modern Rheumatology|February 14, 2016
Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sjögren's syndromeAkihiro Mukaino, Shunya Nakane, Osamu Higuchi, et al.
Clinical and Experimental Rheumatology|November 7, 2023
Exploratory study on quantitative assessment of skin hardness in patients with systemic sclerosis using SOFTGRAMHiraku Kokubu, Yasuaki Ikuno, Kazuyuki Uchiyama, et al.
International Journal of Hematology|May 19, 2009
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALLArinobu Tojo, Kensuke Usuki, Akio Urabe, et al.
International Journal of Clinical Oncology|November 14, 2018
Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial)Shin Fujisawa, Yasunori Ueda, Kensuke Usuki, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 4, 2018
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line TreatmentMasaya Okada, Jun Imagawa, Hideo Tanaka, et al.
Pageof 21